$2.20
$-0.03 (-1.35%)
End-of-day quote: 05/30/2024
NasdaqCM:NEPH
Nephros Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2010 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$14.24M | $9.98M | $10.40M | $8.56M | $10.33M | $5.69M | $3.81M | $1.94M | $2.94M | |
| GM % | Gross Margin % |
|
59.03% | 47.43% | 55.20% | 57.39% | 58.87% | 56.32% | 60.17% | 54.53% | 38.19% | |
| OM | Operating Margin |
|
-11.19% | -43.46% | -41.67% | -52.61% | -32.04% | -52.45% | -58.44% | -166.98% | -64.30% | |
| EPS | Earnings Per Share |
|
$0.00 | $-0.15 | $-0.73 | $-0.46 | $-0.52 | $-0.41 | $-0.47 | $-0.18 | $-0.36 | $-8.37 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
10.54m | 10.3m | 10.26m | 9.87m | 8.06m | 7.13m | 6.14m | 5.4m | 0.23m | |
| OCF | Operating Cash Flow |
|
$0.83M | $-3.23M | $-1.42M | $-6.90M | $-2.28M | $-3.66M | $-0.08M | $-3.82M | $-1.29M | |
| FCF | Free Cash Flow |
|
$0.82M | $-3.37M | $-1.50M | $-6.84M | $-2.29M | $0.00M | $0.00M | $-3.83M | $-1.32M | |
| FCFS | Free Cash Flow Per Share |
|
$0.07 | $-0.33 | $-0.15 | $-0.79 | $-0.30 | $-0.53 | $-0.01 | $-0.99 | $-5.70 |
